• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Dariohealth Targets Physical Retail with Its Mobile-friendly Diabetes Management Platform

Share:

November 26, 2019

The announcement comes not long after competitor One Drop began rolling out its similar offering in Apple Stores and Walmarts.

DarioHealth is the latest to bring its mobile-friendly glucose management system to store shelves, with the company announcing today that it will be bringing its so-called “Membership-in-a-Box” to physical retail chains like Best Buy.

The offering, already available through Best Buy’s online storefront, consists of the company’s connected blood glucose meter, 25 test strips, 10 lancets, 10 covers and a three-month membership consisting of DarioHealth’s digital management offering and comped resupply shipments (as determined by usage logged in the app). This membership also includes the company’s digital personal coaching and education features.

The starter kit currently runs for $69.99 on Best Buy’s marketplace, although DarioHealth’s announcement does not mention whether this price will be adjusted at all for the in-store offering.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The company also did not specify in its announcement which retail stores other than Best Buy would be carrying the product, although CEO Erez Raphael did note in the company’s most recent earnings call that DarioHealth had also made an arrangement with supermarket chain Giant Eagle.

WHY IT MATTERS

On-shelf offerings of the connected glucose management hardware and service have an opportunity to reach a new slice of the market that may not actively be seeking digital diabetes support, especially if the products are being displayed in non-electronics stores. But even with this announcement the company has remained consistent in promoting a software-as-a-service business model, and notes that 75% of memberships sold through its app are renewed by users.

“We believe that Dario’s membership has great success because it offers simplicity, continuity and peace of mind to users for a low price. All Dario memberships include an unlimited, automated supply of test strips and the premium memberships include unlimited access to a personal Dario coach,” said Olivier Jarry, President and CCO, DarioHealth. “By selling our membership in physical stores, we hope to increase Dario’s reach to the millions of consumers who visit Best Buy each year while potentially increasing our recurring revenue streams.”

THE LARGER TREND

DarioHealth’s new strategy falls right in line with its competitor One Drop, which announced during the summer that certain US Apple Stores would begin carrying its wireless blood glucose monitor. In early October, the company revealed additional plans to bring its offering to “hundreds” of Walmart retail locations in the US.

The new option for consumers comes alongside a broader push at DarioHealth to expand its B2B operations across self-insured employers, clinics, providers and retail. During the most recent earnings call, Raphael made specific mention of these retail agreements with Best Buy and Giant Eagle, as well as a “few more in the pipeline.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 27 Healthcare Consumer Insight & Digital Engagement Trends to Watch27 Healthcare Consumer Insight & Digital Engagement Trends to Watch
  • MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
  • XtalPi and CK Life Sciences to Collaborate in AI-Empowered Tumour Vaccine Research and Development, Opening a New Paradigm for Scientific InnovationXtalPi and CK Life Sciences to Collaborate in AI-Empowered Tumour Vaccine Research and Development, Opening a New Paradigm for Scientific Innovation
  • ValGenesis and Brevitas Announce Strategic PartnershipValGenesis and Brevitas Announce Strategic Partnership
  • Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston BiomedicalSumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical
  • Pacgen Announces Proposed Acquisition by General Biologicals CorporationPacgen Announces Proposed Acquisition by General Biologicals Corporation
  • 2 Supply Chain Priorities To Watch In 20202 Supply Chain Priorities To Watch In 2020
  • Patient Payment Strategies to Accelerate Cash Flow Amid COVID-19Patient Payment Strategies to Accelerate Cash Flow Amid COVID-19

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications